NM_000038.6:c.7514G>A

Variant summary

Our verdict is Benign. Variant got -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBS1BS2

The NM_000038.6(APC):​c.7514G>A​(p.Arg2505Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00128 in 1,613,984 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00094 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0013 ( 6 hom. )

Consequence

APC
NM_000038.6 missense

Scores

1
9
9

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:24

Conservation

PhyloP100: 2.99
Variant links:
Genes affected
APC (HGNC:583): (APC regulator of WNT signaling pathway) This gene encodes a tumor suppressor protein that acts as an antagonist of the Wnt signaling pathway. It is also involved in other processes including cell migration and adhesion, transcriptional activation, and apoptosis. Defects in this gene cause familial adenomatous polyposis (FAP), an autosomal dominant pre-malignant disease that usually progresses to malignancy. Mutations in the APC gene have been found to occur in most colorectal cancers, where disease-associated mutations tend to be clustered in a small region designated the mutation cluster region (MCR) and result in a truncated protein product. [provided by RefSeq, Jun 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -18 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.12488851).
BP6
Variant 5-112843108-G-A is Benign according to our data. Variant chr5-112843108-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 127319.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-112843108-G-A is described in Lovd as [Likely_benign]. Variant chr5-112843108-G-A is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4_exome allele frequency = 0.00131 (1917/1461732) while in subpopulation NFE AF= 0.0016 (1784/1111886). AF 95% confidence interval is 0.00154. There are 6 homozygotes in gnomad4_exome. There are 944 alleles in male gnomad4_exome subpopulation. Median coverage is 34. This position pass quality control queck.
BS2
High AC in GnomAd4 at 143 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
APCNM_000038.6 linkc.7514G>A p.Arg2505Gln missense_variant Exon 16 of 16 ENST00000257430.9 NP_000029.2 P25054-1Q4LE70

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
APCENST00000257430.9 linkc.7514G>A p.Arg2505Gln missense_variant Exon 16 of 16 5 NM_000038.6 ENSP00000257430.4 P25054-1
ENSG00000258864ENST00000520401.1 linkn.229-13541G>A intron_variant Intron 3 of 7 3 ENSP00000454861.1 H3BNH8

Frequencies

GnomAD3 genomes
AF:
0.000940
AC:
143
AN:
152134
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000507
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00186
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00165
Gnomad OTH
AF:
0.000479
GnomAD3 exomes
AF:
0.000824
AC:
207
AN:
251232
Hom.:
0
AF XY:
0.000877
AC XY:
119
AN XY:
135766
show subpopulations
Gnomad AFR exome
AF:
0.000492
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000544
Gnomad SAS exome
AF:
0.000849
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00151
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.00131
AC:
1917
AN:
1461732
Hom.:
6
Cov.:
34
AF XY:
0.00130
AC XY:
944
AN XY:
727162
show subpopulations
Gnomad4 AFR exome
AF:
0.000269
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000504
Gnomad4 SAS exome
AF:
0.000881
Gnomad4 FIN exome
AF:
0.0000187
Gnomad4 NFE exome
AF:
0.00160
Gnomad4 OTH exome
AF:
0.000745
GnomAD4 genome
AF:
0.000939
AC:
143
AN:
152252
Hom.:
0
Cov.:
32
AF XY:
0.000900
AC XY:
67
AN XY:
74452
show subpopulations
Gnomad4 AFR
AF:
0.000506
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00187
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00165
Gnomad4 OTH
AF:
0.000474
Alfa
AF:
0.00115
Hom.:
0
Bravo
AF:
0.000790
TwinsUK
AF:
0.00162
AC:
6
ALSPAC
AF:
0.00156
AC:
6
ESP6500AA
AF:
0.000454
AC:
2
ESP6500EA
AF:
0.00151
AC:
13
ExAC
AF:
0.000815
AC:
99
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00104
EpiControl
AF:
0.00113

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:24
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:12
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Feb 20, 2017
PreventionGenetics, part of Exact Sciences
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Mar 14, 2016
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Variant summary: The APC c.7514G>A variant affects a conserved nucleotide, resulting in amino acid change from Arg to Gln. 2/4 in-silico tools predict this variant to be benign (SNPs&GO not captured due to low reliability index). This variant was found in 102/125206 control chromosomes (1 homozygote) at a frequency of 0.0008147, which is about 14 times the maximal expected frequency of a pathogenic APC allele (0.0000602), suggesting this variant is benign. Thie variant has been reported in patients with MAP/FAP, CRC or pancreatic cancer. In one CRC family, this variant did not co-segregate with the disease (Zhou_2004), highly suggesting this variant is not causative. In addition, multiple clinical laboratories classified this variant as benign/likely benign. Taken together, this variant was classified as benign. -

Feb 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

APC: BS1 -

Nov 03, 2021
Institute for Clinical Genetics, University Hospital TU Dresden, University Hospital TU Dresden
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

The p.Arg2505Gln variant was identified in 4 of 2376 proband chromosomes (frequency: 0.002) from individuals with colorectal adenomas or colorectal cancer (Azzopardi 2008, Lefevre 2012, Zhou 2004) and was present in 2 of 3862 control chromosomes (frequency: 0.001). The variant was also listed at a frequency of 0.001 in the “NHLBI Exome Sequencing Project”, increasing the likelihood that this may be a low frequency benign variant in certain populations of origin. In a study by Zhou (2004), the variant was found incidentally in two members of a family with hereditary colorectal cancer but did not segregate with disease in other affected family members. The variant was listed in dbSNP (ID: rs147549623) and the “InSiGHT Colon Cancer Database”, but was not identified in other databases searched, including HGMD, UMD and COSMIC. The p.Arg2505 residue is conserved in mammals and lower organisms; however, computational analyses (PolyPhen-2, SIFT, AlignGVGD) provide inconsistent predictions regarding the impact of the variant amino acid to the protein and this information is not very predictive of pathogenicity. Additional study is needed to determine the clinical significance of this variant. In summary, based on the above information, the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more benign role for this variant. This variant is classified as predicted benign. -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Nov 01, 2022
Quest Diagnostics Nichols Institute San Juan Capistrano
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Aug 30, 2021
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Hereditary cancer-predisposing syndrome Benign:5
May 20, 2016
Color Diagnostics, LLC DBA Color Health
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Apr 16, 2024
Institute for Biomarker Research, Medical Diagnostic Laboratories, L.L.C.
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Oct 15, 2020
Sema4, Sema4
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: curation

- -

Jul 31, 2017
True Health Diagnostics
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Jul 31, 2018
Ambry Genetics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

not specified Benign:3
Feb 19, 2018
GeneDx
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Mar 04, 2025
Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Familial adenomatous polyposis 1 Benign:3
May 28, 2019
Mendelics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Apr 09, 2024
Myriad Genetics, Inc.
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is considered benign. This variant has been observed in conjunction with multiple pathogenic variants, reducing the likelihood this variant itself is pathogenic. This variant is strongly associated with less severe personal and family histories of cancer, typical for individuals without pathogenic variants in this gene [PMID: 25085752]. -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Classic or attenuated familial adenomatous polyposis Benign:1
Sep 26, 2024
All of Us Research Program, National Institutes of Health
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.14
T
BayesDel_noAF
Uncertain
0.0
CADD
Uncertain
25
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.28
T;T
Eigen
Uncertain
0.63
Eigen_PC
Uncertain
0.64
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Uncertain
0.93
.;D
M_CAP
Uncertain
0.10
D
MetaRNN
Benign
0.12
T;T
MetaSVM
Uncertain
0.22
D
MutationAssessor
Uncertain
2.1
M;M
PrimateAI
Benign
0.37
T
PROVEAN
Benign
0.070
N;N
REVEL
Uncertain
0.48
Sift
Benign
0.23
T;T
Sift4G
Benign
0.17
T;T
Polyphen
1.0
D;D
Vest4
0.59
MVP
0.84
ClinPred
0.057
T
GERP RS
6.0
Varity_R
0.094
gMVP
0.59

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs147549623; hg19: chr5-112178805; COSMIC: COSV57337857; COSMIC: COSV57337857; API